Product Image

Acetyl L-Carnitine 500 mg

Carlson
4.8
★ ★ ★ ★ ★
(402 ratings)
Acetyl L-Carnitine 500 mg
Product Image
Score85
A straightforward one-capsule ALCAR HCl formula with a useful starting amount. Strong focus is offset by limited verification detail.
How scoring works
Quantity:60 Capsule(s) • (60 servings)
Goals:
Mental Focus
Metabolism Boost
Brain Health
Productivity Boost
Cognitive Support
Energy
Anti-Aging

Score 85

A straightforward one-capsule ALCAR HCl formula with a useful starting amount. Strong focus is offset by limited verification detail.
How scoring works
$20.32($0.33 per serving)
iHerb
$ 20.32
Report prices

Analysis

Acetyl-L-carnitine HCl is the sole active and is supplied at a practical starting amount. The acetylated form supports brain access and mitochondrial energy.

Its strongest fit is cognitive energy or fatigue support rather than direct weight loss. A single ingredient keeps the purpose clear but does not cover stress resilience or acute alertness.

The moderate serving count works for a trial or regular routine. More complete sourcing and testing disclosure would improve confidence.

Who is it for
  • Adults seeking simple ALCAR support
  • Users wanting a manageable trial size
Best for
  • Cognitive-energy routines
  • Stimulant-free mitochondrial support

Pros

  • Clearly stated ALCAR HCl
  • Useful amount
  • One-capsule serving

Cons

  • No branded source
  • No purity testing supplied
  • Limited broader formula coverage

Warnings

  • May cause digestive upset or restlessness
  • Take earlier if sleep is affected
  • Discuss use with thyroid or seizure medicines

Nutrient quality

94 Highest impact

A specific acetyl-L-carnitine salt and meaningful amount support the intended energy and cognitive uses. The focused formula avoids obvious filler or excessive dosing.

.

Ingredient transparency

83 Highest impact

The active form and amount are disclosed clearly without a hidden blend. Daily-use directions and non-active ingredients are not supplied.

.

Customer satisfaction

66 High impact

The available rating is strong and the sample is moderate. Detailed feedback was not supplied, so repeated complaints and alignment with the intended use remain uncertain.

.

Value for money

92 Highest impact

A meaningful focused amount and strong supply deliver strong practical value. No unnecessary active extras inflate the formula.

.
Report analysis

Goals

Mental Focus
Impact
Highest effect
B+ Goal FitA Strength of SupportC CoverageA+ Formula Quality
Acetyl L-Carnitine · 500 mg

Acetyl-L-carnitine supports brain energy and acetylcholine production in a form that can reach the brain. The clearly disclosed amount is clinically useful for cognitive and metabolic support.

The single-active formula offers focused depth without a stimulant. It may support mental energy more than immediate alertness, and branded sourcing or purity testing is not disclosed.

Study evidence
Acetyl L-Carnitine Supportive 7 studies
Metabolism Boost
Impact
Highest effect
B+ Goal FitB+ Strength of SupportC+ CoverageA+ Formula Quality
Acetyl L-Carnitine · 500 mg

Acetyl-L-carnitine directly supports transport and use of fatty acids in mitochondria. The acetylated form is clearly identified at a useful amount in one capsule.

The focused design offers good depth for cellular-energy metabolism without thermogenic or glycemic ingredients. Missing branded sourcing and purity testing leave a modest quality gap.

Study evidence
Acetyl L-Carnitine Adverse 1 study
Brain Health
Impact
Highest effect
A- Goal FitA- Strength of SupportC CoverageA Formula Quality

Acetyl-L-carnitine supports neural energy metabolism in a form that reaches brain tissue more readily than standard carnitine. The disclosed amount is useful and straightforward.

The focused formula does not cover stress adaptation, structural fats, or direct memory signaling. Branded sourcing and independent purity testing are not identified.

Study evidence
Acetyl L-Carnitine Supportive 19 studies
Productivity Boost
Impact
Highest effect
B Goal FitA Strength of SupportC- CoverageA+ Formula Quality
Acetyl L-Carnitine · 500 mgAcetyl L-Carnitine · 500 mg

Acetyl L-carnitine supports mitochondrial brain energy and acetylcholine-related metabolism, making it relevant to mental stamina. Human evidence is useful for fatigue and selected cognitive populations but less certain for a rapid productivity boost in healthy adults.

The 500 mg amount reaches a meaningful range and the hydrochloride form is clearly identified. The focused formula provides strong depth without alertness or stress-adaptation coverage.

Study evidence
Acetyl L-Carnitine Supportive 1 study
Acetyl L-Carnitine Supportive 1 study
Cognitive Support
Impact
Highest effect
B Goal FitA Strength of SupportC CoverageA+ Formula Quality
Acetyl L-Carnitine · 500 mg

Acetyl L-carnitine directly supports brain-cell energy and cholinergic activity, giving the formula a credible cognitive role. The 500 mg serving is clinically useful and fully disclosed.

The acetylated form is appropriate for brain access, although branded sourcing and purity testing are not stated. Its focused design favors mental-energy support over broad coverage of memory, circulation, or stress pathways.

Study evidence
Acetyl L-Carnitine Supportive 20 studies
Energy
Impact
High effect
B+ Goal FitB+ Strength of SupportC- CoverageA+ Formula Quality
Acetyl L-Carnitine · 500 mg

Acetyl L-carnitine directly supports transport and use of fatty acids in mitochondria, linking the 500 mg serving to cellular fuel production. The acetyl form also has a plausible role in mental energy, though benefits vary by baseline need.

The single-ingredient formula is focused and clearly disclosed, but the serving is at the lower end of commonly used supplemental amounts. No ingredient covers acute alertness or stress resilience, so the product is better viewed as targeted mitochondrial support.

Study evidence
Acetyl L-Carnitine Supportive 19 studies

Ingredients

IngredientAmount per serving
Acetyl L-Carnitine (Acetyl L-Carnitine HCl)
500 mg
Gluten Free Adults 18–50 Women
Report overview
A- Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyB Value

The clearly identified acetyl form and clinically useful serving support cognitive and metabolic use. The label states the full active amount, while the available details do not confirm branded sourcing or independent purity testing. Cost efficiency appears favorable for a single-ingredient formula.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
    Malaguarnera M; Gargante MP; Cristaldi E; Vacante M; Risino C; Cammalleri L; Pennisi G; Rampello L · Digestive diseases and sciences · 2008
    Randomized trial125 participantsCognitive Support Brain Health forAcetyl L-Carnitine
  2. Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
    Malaguarnera M; Vacante M; Motta M; Giordano M; Malaguarnera G; Bella R; Nunnari G; Rampello L; Pennisi G · Metabolic brain disease · 2012
    Randomized trial61 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  3. Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.
    Malaguarnera M; Vacante M; Giordano M; Pennisi G; Bella R; Rampello L; Malaguarnera M; Li Volti G; Galvano F · The American journal of clinical nutrition · 2011
    Randomized trial121 participantsEnergy forAcetyl L-Carnitine
  4. Acetyl L-carnitine slows decline in younger patients with Alzheimer's disease: a reanalysis of a double-blind, placebo-controlled study using the trilinear approach.
    Brooks JO; Yesavage JA; Carta A; Bravi D · International psychogeriatrics · 1998
    Randomized trial334 participantsCognitive Support forAcetyl L-Carnitine
  5. A 1-year controlled trial of acetyl-l-carnitine in early-onset AD.
    Thal LJ; Calvani M; Amato A; Carta A · Neurology · 2000
    Randomized trial229 participantsCognitive Support forAcetyl L-Carnitine
  6. Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia.
    Rai G; Wright G; Scott L; Beston B; Rest J; Exton-Smith AN · Current medical research and opinion · 1990
    Randomized trial36 participantsBrain Health forAcetyl L-Carnitine
  7. Carnitine for fatigue in multiple sclerosis.
    Tejani AM; Wasdell M; Spiwak R; Rowell G; Nathwani S · The Cochrane database of systematic reviews · 2012
    Systematic review1 studies pooledEnergy forAcetyl L-Carnitine
  8. Mental impairment in aging: selection of patients, methods of evaluation and therapeutic possibilities of acetyl-L-carnitine.
    Passeri M; Iannuccelli M; Ciotti G; Bonati PA; Nolfe G; Cucinotta D · International journal of clinical pharmacology research · 1989
    Randomized trial30 participantsBrain Health forAcetyl L-Carnitine
  9. Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients.
    Rossini M; Di Munno O; Valentini G; Bianchi G; Biasi G; Cacace E; Malesci D; La Montagna G; Viapiana O; Adami S · Clinical and experimental rheumatology · 2007
    Randomized trial102 participantsEnergy forAcetyl L-Carnitine
  10. The Effect of Acylcarnitines on Cognitive Function: A Two-Sample Mendelian Randomization Study.
    Luan S; Zhang J; Wang C; Wang Z; Zhou J · Brain and behavior · 2025
    OtherBrain Health forAcetyl L-Carnitine
  11. Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohort.
    Montanari S; Jansen R; Schranner D; Kastenmüller G; Arnold M; Janiri D; Sani G; Bhattacharyya S; Mahmoudian Dehkordi S; Dunlop BW; Rush AJ; Penninx BWHJ; Kaddurah-Daouk R; Milaneschi Y · Translational psychiatry · 2025
    Cohort study2,574 participantsEnergy forAcetyl L-Carnitine
  12. Acetyl-L-carnitine Slows the Progression from Prefrailty to Frailty in Older Subjects: A Randomized Interventional Clinical Trial.
    Malaguarnera G; Catania VE; Bertino G; Chisari LM; Castorina M; Bonfiglio C; Cauli O; Malaguarnera M · Current pharmaceutical design · 2022
    Randomized trial92 participantsAnti-Aging forAcetyl L-Carnitine
  13. Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
    Spagnoli A; Lucca U; Menasce G; Bandera L; Cizza G; Forloni G; Tettamanti M; Frattura L; Tiraboschi P; Comelli M · Neurology · 1991
    Randomized trial130 participantsBrain Health Cognitive Support forAcetyl L-Carnitine
  14. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
    Herrmann WM; Dietrich B; Hiersemenzel R · International journal of clinical pharmacology research · 1990
    Randomized trialBrain Health forAcetyl L-Carnitine
  15. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
    Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U · International journal of clinical pharmacology research · 1990
    Randomized trial60 participantsBrain Health Mental Focus forAcetyl L-Carnitine
  16. A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys.
    Torrioli MG; Vernacotola S; Peruzzi L; Tabolacci E; Mila M; Militerni R; Musumeci S; Ramos FJ; Frontera M; Sorge G; Marzullo E; Romeo G; Vallee L; Veneselli E; Cocchi E; Garbarino E; Moscato U; Chiurazzi P; D'Iddio S; Calvani M; Neri G · American journal of medical genetics. Part A · 2008
    Randomized trial63 participantsCognitive Support forAcetyl L-Carnitine
  17. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
    Malaguarnera M; Gargante MP; Cristaldi E; Colonna V; Messano M; Koverech A; Neri S; Vacante M; Cammalleri L; Motta M · Archives of gerontology and geriatrics · 2008
    Randomized trial96 participantsCognitive Support forAcetyl L-Carnitine
  18. The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirin.
    Malaguarnera M; Vacante M; Bertino G; Neri S; Malaguarnera M; Gargante MP; Motta M; Lupo L; Chisari G; Bruno CM; Pennisi G; Bella R · Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2012
    Randomized trial60 participantsEnergy forAcetyl L-Carnitine
  19. Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy.
    Malaguarnera M; Bella R; Vacante M; Giordano M; Malaguarnera G; Gargante MP; Motta M; Mistretta A; Rampello L; Pennisi G · Scandinavian journal of gastroenterology · 2011
    Randomized trial67 participantsEnergy forAcetyl L-Carnitine
  20. A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy.
    Sun Y; Shu Y; Liu B; Liu P; Wu C; Zheng R; Zhang X; Zhuang Z; Deng Y; Zheng L; Xu Q; Jiang B; Ouyang X; Gao J; Xu N; Li X; Jiang S; Liang C; Yao Y · Experimental and therapeutic medicine · 2020
    Randomized trial239 participantsEnergy forAcetyl L-Carnitine
  21. Metabolomic biomarkers for (R, S)-ketamine and (S)-ketamine in treatment-resistant depression and healthy controls: A systematic review.
    Kumar R; Nuñez NA; Joshi N; Joseph B; Verde A; Seshadri A; Cuellar Barboza AB; Prokop LJ; Medeiros GC; Singh B · Bipolar disorders · 2024
    Systematic reviewEnergy forAcetyl L-Carnitine
  22. Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial.
    Malaguarnera G; Pennisi M; Gagliano C; Vacante M; Malaguarnera M; Salomone S; Drago F; Bertino G; Caraci F; Nunnari G; Malaguarnera M · Hepatitis monthly · 2014
    Randomized trial62 participantsMental Focus Productivity Boost forAcetyl L-Carnitine
  23. [Psycho-functional changes in attention and learning under the action of L-acetylcarnitine in 17 young subjects. A pilot study of its use in mental deterioration].
    Lino A; Boccia MM; Rusconi AC; Bellomonte L; Cocuroccia B · La Clinica terapeutica · 1992
    Non-randomized trial17 participantsMental Focus forAcetyl L-Carnitine
  24. Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial.
    Arnold LE; Amato A; Bozzolo H; Hollway J; Cook A; Ramadan Y; Crowl L; Zhang D; Thompson S; Testa G; Kliewer V; Wigal T; McBurnett K; Manos M · Journal of child and adolescent psychopharmacology · 2008
    Randomized trial112 participantsMental Focus forAcetyl L-Carnitine
  25. Acetyl-L-carnitine for patients with hepatic encephalopathy.
    Martí-Carvajal AJ; Gluud C; Arevalo-Rodriguez I; Martí-Amarista CE · The Cochrane database of systematic reviews · 2019
    Meta-analysis398 participants5 studies pooledMental Focus forAcetyl L-Carnitine
  26. Low Bioavailability and High TMAO Production: Novel Insights Into Acetylcarnitine and Carnitine Metabolism.
    Krims-Davis K; Ozola M; Razzivina V; Gukalova B; Konrade I; Dambrova M; Liepinsh E · Molecular nutrition & food research · 2025
    Randomized trialMetabolism Boost forAcetyl L-Carnitine